BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24561703)

  • 21. Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats.
    Tan J; Wang JM; Leenen FH
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):158-64. PubMed ID: 15752941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of a novel angiotensin-converting enzyme-inhibitory tripeptide from enzymatic hydrolysis of soft-shelled turtle (Pelodiscus sinensis) egg white: in vitro, in vivo, and in silico study.
    Rawendra RD; Aisha ; Chen SH; Chang CI; Shih WL; Huang TC; Liao MH; Hsu JL
    J Agric Food Chem; 2014 Dec; 62(50):12178-85. PubMed ID: 25402658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.
    Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
    Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V
    J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II.
    Sun Y; Ratajska A; Weber KT
    J Lab Clin Med; 1995 Jul; 126(1):95-101. PubMed ID: 7602241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin Inhibition.
    Arendse LB; Cozier GE; Eyermann CJ; Basarab GS; Schwager SL; Chibale K; Acharya KR; Sturrock ED
    J Med Chem; 2022 Feb; 65(4):3371-3387. PubMed ID: 35113565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.
    Redelinghuys P; Nchinda AT; Chibale K; Sturrock ED
    Biol Chem; 2006 Apr; 387(4):461-6. PubMed ID: 16606345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence evaluation of two brands of lisinopril tablets by in vitro comparative dissolution test and in vivo bioequivalence test.
    Shin MC; Kim JK; Kim CK
    Arzneimittelforschung; 2008; 58(1):11-7. PubMed ID: 18368945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the bioequivalence and pharmacokinetics of two lisinopril tablet formulations after single oral administration in healthy volunteers.
    Georgarakis M; Tsakalof A; Zougrou F; Kontopoulos G; Tsiptsios I
    Arzneimittelforschung; 2004; 54(1):15-9. PubMed ID: 14979604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of angiotensin I-converting enzyme N-domain selectivity using positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides.
    Bersanetti PA; Sabatini RA; Matos BS; Douglas RG; Nchinda A; Juliano MA; Pesquero JB; Sturrock ED; Carmona AK
    Biol Chem; 2012 Dec; 393(12):1547-54. PubMed ID: 23667908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression.
    Femia FJ; Maresca KP; Hillier SM; Zimmerman CN; Joyal JL; Barrett JA; Aras O; Dilsizian V; Eckelman WC; Babich JW
    J Nucl Med; 2008 Jun; 49(6):970-7. PubMed ID: 18483087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats.
    Kuno A; Yamada T; Masuda K; Ogawa K; Sogawa M; Nakamura S; Nakazawa T; Ohara H; Nomura T; Joh T; Shirai T; Itoh M
    Gastroenterology; 2003 Apr; 124(4):1010-9. PubMed ID: 12671898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure-activity relationship.
    Jimsheena VK; Gowda LR
    Peptides; 2010 Jun; 31(6):1165-76. PubMed ID: 20214946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic-pharmacodynamic model relating lisinopril plasma concentrations to regional hemodynamic effects in healthy volunteers.
    Bellissant E; Nguyen PC; Giudicelli JF
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):470-8. PubMed ID: 8877596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted catalytic inactivation of angiotensin converting enzyme by lisinopril-coupled transition-metal chelates.
    Joyner JC; Hocharoen L; Cowan JA
    J Am Chem Soc; 2012 Feb; 134(7):3396-410. PubMed ID: 22200082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
    van Esch JH; van Gool JM; de Bruin RJ; Payne JR; Montgomery HE; Hectors M; Deinum J; Dive V; Jan Danser AH
    J Hypertens; 2008 Apr; 26(4):706-13. PubMed ID: 18327080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of some pharmacokinetic parameters of 5 angiotensin-converting enzyme inhibitors in normal beagles.
    Hamlin RL; Nakayama T
    J Vet Intern Med; 1998; 12(2):93-5. PubMed ID: 9560765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.
    Johnston CI; Fabris B; Yamada H; Mendelsohn FA; Cubela R; Sivell D; Jackson B
    J Hypertens Suppl; 1989 Sep; 7(5):S11-6. PubMed ID: 2553899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.